(Q44407172)

2 December 2017

title

Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects (English)

1 reference

2 December 2017

Corticotropin-Releasing Factor Testing Reveals a Dose-Dependent Difference in Methadone Maintained Vs Control Subjects (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

25 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

25 December 2023

5

Mary Jeanne Kreek

1 reference

2 December 2017

Gavin Bart

2

1 reference

2 December 2017

Mark Green

series ordinal

3

1 reference

2 December 2017

Ann Ho

series ordinal

4

1 reference

2 December 2017

James H. Schluger

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700714

25 December 2023

language of work or name

English

0 references

publication date

26 March 2003

1 reference

full work available at URL

2 December 2017

https://www.nature.com/articles/1300156.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700714

http://www.nature.com/articles/1300156.pdf

25 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

http://www.nature.com/articles/1300156

25 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

25 December 2023

published in

Neuropsychopharmacology

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

985-994

1 reference

Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Mu opioid receptor gene variants: lack of association with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Secretion of Corticotrophin and Its Hypothalamic Releasing Factor in Response to Morphine and Opioid Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Differences in Hypothalamo-Pituitary-Adrenocortical Activity in the Rat after Acute and Prolonged Treatment with Morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Methadone plasma level: sustained by a reservoir of drug in tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Catecholamine and 17-hydroxycorticosteroid excretion during a cycle of morphine dependence in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Ketoconazole reduces low dose cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Metyrapone-induced withdrawal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Stress, corticotropin-releasing factor, and drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

CRF antagonist partially reverses CRF- and stress-induced effects on feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Medical Safety and Side Effects of Methadone in Tolerant Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Medical complications in methadone patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Stereoselective disposition of methadone in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Drug dependence: stress and dysregulation of brain reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Opioid receptor and peptide gene polymorphisms: potential implications for addictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Use of naltrexone as a provocative test for hypothalamic-pituitary hormone function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

The role of CRF in the release of ACTH by opiate agonists and antagonists in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

A genome-wide search for genes that relate to a low level of response to alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Corticotropin releasing factor produces behavioural activation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Family history of alcoholism and hypothalamic opioidergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

Nonreplication of association between ?-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

The levels of methadone in the plasma in methadone maintenance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

A comparison of the clearance of ovine and human corticotrophin-releasing hormone (CRH) in man and sheep: a possible role for CRH-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

Human Corticotropin-Releasing Factor in Man: Pharmacokinetic Properties and Dose-Response of Plasma Adrenocorticotropin and Cortisol Secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

Short-term hormonal effects of naloxone in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

Adrenocorticotropin responses following administration of ethanol and ovine corticotropin-releasing hormone in the sons of alcoholics and control subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300156

7 January 2021

NIDA research monograph

34

67

362

TR Kosten

1986

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

25 December 2023

NIDA research monograph

46

180

48

KS LaForge

2000

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

Alcoholism: Clinical and Experimental Research

25 December 2023

64

22

2108

T Sander

1998

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

25 December 2023

Pharmacological Reviews

66

53

209

Z Sarnyai

2001

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

The New England Journal of Medicine

25 December 2023

80

300

1056

J Volavka

1979

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

Alcoholism: Clinical and Experimental Research

25 December 2023

86

24

1575

Y Zhou

2000

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300156

25 December 2023

Identifiers

0 references

1 reference